OLMESARTAN FOR IMMUNE MODULATION AND ATTENUATION OF MYOCARDIAL FIBROSIS IN OBESITY-INDUCED CARDIAC DYSFUNCTION
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Hypertension"
DOI: 10.1097/01.hjh.0001117136.51830.17
Abstract: Conclusions: Patients with exogenous constitutional obesity and arterial hypertension have complex disorders on the part of most systems, including changes in metabolism, lipid peroxidation, and the exchange of trace elements. read more here.
Keywords: olmesartan immune; modulation attenuation; myocardial fibrosis; obesity ... See more keywords